Kimball AB - Search Results

1

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD. Mehdizadeh A, et al. Among authors: kimball ab. Exp Dermatol. 2018 Jan;27(1):104-112. doi: 10.1111/exd.13445. Epub 2017 Nov 15. Exp Dermatol. 2018. PMID: 28898476

2

Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.

Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB. Kimball AB, et al. Ann Intern Med. 2012 Dec 18;157(12):846-55. doi: 10.7326/0003-4819-157-12-201212180-00004. Ann Intern Med. 2012. PMID: 23247938 Clinical Trial.

3

Counterpoint: analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States.

Sung S, Kimball AB. Sung S, et al. Among authors: kimball ab. J Am Acad Dermatol. 2013 Nov;69(5):818-819. doi: 10.1016/j.jaad.2013.06.043. J Am Acad Dermatol. 2013. PMID: 24124816 No abstract available.

4

The validity of the diagnostic code for hidradenitis suppurativa in an electronic database.

Kim GE, Shlyankevich J, Kimball AB. Kim GE, et al. Among authors: kimball ab. Br J Dermatol. 2014 Aug;171(2):338-42. doi: 10.1111/bjd.13041. Epub 2014 Jul 26. Br J Dermatol. 2014. PMID: 24712395 Free PMC article.

5

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.

Kimball AB, Jemec GB, Yang M, Kageleiry A, Signorovitch JE, Okun MM, Gu Y, Wang K, Mulani P, Sundaram M. Kimball AB, et al. Br J Dermatol. 2014 Dec;171(6):1434-42. doi: 10.1111/bjd.13270. Epub 2014 Nov 11. Br J Dermatol. 2014. PMID: 25040429 Clinical Trial.

6

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.

Kimball AB, Sobell JM, Zouboulis CC, Gu Y, Williams DA, Sundaram M, Teixeira HD, Jemec GB. Kimball AB, et al. J Eur Acad Dermatol Venereol. 2016 Jun;30(6):989-94. doi: 10.1111/jdv.13216. Epub 2015 Jul 22. J Eur Acad Dermatol Venereol. 2016. PMID: 26201313 Free PMC article. Clinical Trial.

7

Systemic associations of hidradenitis suppurativa.

Kohorst JJ, Kimball AB, Davis MD. Kohorst JJ, et al. Among authors: kimball ab. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S27-35. doi: 10.1016/j.jaad.2015.07.055. J Am Acad Dermatol. 2015. PMID: 26470611 Review.

8

Hidradenitis suppurativa: Epidemiology and scope of the problem.

Jemec GB, Kimball AB. Jemec GB, et al. Among authors: kimball ab. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7. doi: 10.1016/j.jaad.2015.07.052. J Am Acad Dermatol. 2015. PMID: 26470614 Review.

9

Pyrithione zinc as a general management strategy for hidradenitis suppurativa.

Danesh MJ, Kimball AB. Danesh MJ, et al. Among authors: kimball ab. J Am Acad Dermatol. 2015 Nov;73(5):e175. doi: 10.1016/j.jaad.2015.07.026. J Am Acad Dermatol. 2015. PMID: 26475559 No abstract available.

10

The Handicap of Hidradenitis Suppurativa.

Deckers IE, Kimball AB. Deckers IE, et al. Among authors: kimball ab. Dermatol Clin. 2016 Jan;34(1):17-22. doi: 10.1016/j.det.2015.07.003. Epub 2015 Sep 14. Dermatol Clin. 2016. PMID: 26617353 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page